المؤلفون: Ali EM; Clinical Oncology department, Sohag University, Sohag, Egypt. sayedmostafa09@gmail.com, Abdelraheem AG

المصدر: Head & neck oncology [Head Neck Oncol] 2011 Nov 15; Vol. 3, pp. 48. Date of Electronic Publication: 2011 Nov 15.

نوع المنشور: Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: OA Publishing Country of Publication: England NLM ID: 101479704 Publication Model: Electronic Cited Medium: Internet ISSN: 1758-3284 (Electronic) Linking ISSN: 17583284 NLM ISO Abbreviation: Head Neck Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Squamous Cell/*drug therapy , Carcinoma, Squamous Cell/*radiotherapy , Deoxycytidine/*analogs & derivatives , Head and Neck Neoplasms/*drug therapy , Head and Neck Neoplasms/*radiotherapy , Radiation-Sensitizing Agents/*therapeutic use, Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carcinoma, Squamous Cell/pathology ; Combined Modality Therapy ; Deoxycytidine/adverse effects ; Deoxycytidine/therapeutic use ; Disease-Free Survival ; Female ; Head and Neck Neoplasms/pathology ; Humans ; Male ; Middle Aged ; Prospective Studies ; Radiation-Sensitizing Agents/adverse effects ; Young Adult ; Gemcitabine